Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/01/2002CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists
10/01/2002CA2241845C 4,5-dihydronaphth¬1,2-c|isoxazoles and derivatives thereof having cns activity
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/01/2002CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
10/01/2002CA2168113C Therapeutic peptide derivatives
10/01/2002CA2103546C Modified factor vii
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
10/01/2002CA2075358C Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
10/01/2002CA2071520C Elimination of activated lymphocytes
10/01/2002CA2063926C Imidazopyridine
10/01/2002CA2059708C Indole derivatives
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002075302A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
09/26/2002WO2002074970A1 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase
09/26/2002WO2002074956A2 Dopaminergic neuronal survival-promoting factors and uses thereof
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074835A1 Process for producing lactic acid oligomer
09/26/2002WO2002074805A1 Soluble rage protein
09/26/2002WO2002074798A2 The genome of a bifidobacterium
09/26/2002WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors
09/26/2002WO2002074781A1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides
09/26/2002WO2002074774A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
09/26/2002WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074769A1 Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
09/26/2002WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074765A1 Phenyl derivatives 3
09/26/2002WO2002074764A2 Piperazine derivatives and their use as 5-ht1b ligands
09/26/2002WO2002074763A1 Benzimidazol derivatives modulate chemokine receptors
09/26/2002WO2002074761A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074756A2 Urokinase inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074747A1 Farnesyltransferase inhibitors
09/26/2002WO2002074746A1 Benzazepine derivatives
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility
09/26/2002WO2002074741A1 Pyrrolidine ester derivatives with oxytocin modulating acitvity
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors
09/26/2002WO2002074725A1 Novel ligands of nuclear receptor superfamily, process for producing the same and use thereof
09/26/2002WO2002074346A2 Targeting chemical compounds to cells
09/26/2002WO2002074343A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body
09/26/2002WO2002074342A1 Remedies for arteriosclerosis
09/26/2002WO2002074340A1 Process for producing sustained release preparation
09/26/2002WO2002074337A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
09/26/2002WO2002074328A1 Methods of treating respiratory conditions
09/26/2002WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses
09/26/2002WO2002074326A2 Urocortin-iii and uses thereof
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074320A1 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
09/26/2002WO2002074318A1 Il-12 expression controlling agents
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074299A1 TNFα PRODUCTION INHIBITORS
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074291A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
09/26/2002WO2002074289A2 Antitumor compositions containing taxane derivatives
09/26/2002WO2002074282A1 New composition
09/26/2002WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
09/26/2002WO2002074238A2 Water soluble and palatable complexes
09/26/2002WO2002074236A2 Skin whiteners containing hydroxytetronic acid
09/26/2002WO2002074232A2 Antitumor compositions containing taxane derivatives
09/26/2002WO2002074229A2 A combination comprising combretastatin and anticancer agents
09/26/2002WO2002074056A2 Allosteric adenosine receptor modulators
09/26/2002WO2002074048A2 P-glycoproteins and uses thereof
09/26/2002WO2002074045A2 Production of pancreatic islet cells and delivery of insulin
09/26/2002WO2002074042A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
09/26/2002WO2002074036A2 Substituted benzopyranones as telomerase inhibitors
09/26/2002WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
09/26/2002WO2002062780A3 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
09/26/2002WO2002060382A3 Novel compounds and uses thereof
09/26/2002WO2002056755A3 Method for treating cancer
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002040487A3 Benzodiazepine derivatives as gaba a receptor modulators
09/26/2002WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof
09/26/2002WO2002038544A3 3-substituted oxindole beta 3 agonists
09/26/2002WO2002036116A3 Tripeptidyl peptidase inhibitors
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation
09/26/2002WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002WO2002026954A3 Truncated phosphodiesterase-7 polypeptides
09/26/2002WO2002024666A3 4-amino-quinazolines
09/26/2002WO2002004439A3 Thiophene retinoids
09/26/2002WO2002003975A3 Combinations of ssri and estrogenic agents
09/26/2002WO2002000710A3 B7-like molecules and uses thereof
09/26/2002WO2001098332A3 Secreted redox proteins
1 ... 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 ... 1564